{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:02:53Z","timestamp":1791241373188,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012489","name":"Boston Area Diabetes Endocrinology Research Center","doi-asserted-by":"publisher","award":["DK135043"],"award-info":[{"award-number":["DK135043"]}],"id":[{"id":"10.13039\/100012489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD032211-01"],"award-info":[{"award-number":["S10 OD032211-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.118021","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T07:24:16Z","timestamp":1743751456000},"page":"118021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Multi-organ model assessment of neurotoxicity following exposure of liver spheroids to drugs"],"prefix":"10.1016","volume":"186","author":[{"given":"Wei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Anas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baran","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipeng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-8722","authenticated-orcid":false,"given":"Ryan","family":"Hasselkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2732-5080","authenticated-orcid":false,"given":"Darian","family":"Rezania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Sharareh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0748-7096","authenticated-orcid":false,"given":"Luba","family":"Farberov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1009-056X","authenticated-orcid":false,"given":"Dor","family":"Zlotnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Alon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Tenzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Bentwich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5552-6179","authenticated-orcid":false,"given":"Amir","family":"Bein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2025.118021_bib1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nrd.2016.184","article-title":"Phase II and phase III failures: 2013-2015","volume":"15","author":"Harrison","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.biopha.2025.118021_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacbts.2019.10.008","article-title":"Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?","volume":"4","author":"Van Norman","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"issue":"7586","key":"10.1016\/j.biopha.2025.118021_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/bmj.39048.407928.BE","article-title":"Comparison of treatment effects between animal experiments and clinical trials: systematic review","volume":"334","author":"Perel","year":"2007","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.biopha.2025.118021_bib4","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41416-020-01033-x","article-title":"Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials","volume":"123","author":"Atkins","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"2-4","key":"10.1016\/j.biopha.2025.118021_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10937404.2010.483176","article-title":"Toxicity testing in the 21st century: a vision and a strategy","volume":"13","author":"Krewski","year":"2010","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2025.118021_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.amjmed.2023.03.033","article-title":"The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional","volume":"136","author":"Adashi","year":"2023","journal-title":"Am. J. Med"},{"issue":"2","key":"10.1016\/j.biopha.2025.118021_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/03602532.2022.2064487","article-title":"In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation","volume":"54","author":"Mirahmad","year":"2022","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118021_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1039\/C2TX20051A","article-title":"In vitro models for liver toxicity testing","volume":"2","author":"Soldatow","year":"2013","journal-title":"Toxicol. Res (Camb."},{"issue":"8","key":"10.1016\/j.biopha.2025.118021_bib9","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","article-title":"Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury","volume":"91","author":"Proctor","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118021_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00204-012-0968-2","article-title":"Multi-cell type human liver microtissues for hepatotoxicity testing","volume":"87","author":"Messner","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118021_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/dmd.107.017418","article-title":"HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.biopha.2025.118021_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.biopha.2025.118021_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/00498250210128675","article-title":"Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells","volume":"32","author":"Rodriguez-Antona","year":"2002","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.biopha.2025.118021_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00204-016-1694-y","article-title":"Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile","volume":"91","author":"Heslop","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118021_bib15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","article-title":"High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids","volume":"160","author":"Shinozawa","year":"2021","journal-title":"Gastroenterology"},{"issue":"7244","key":"10.1016\/j.biopha.2025.118021_bib16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"issue":"7467","key":"10.1016\/j.biopha.2025.118021_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2025.118021_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040874","article-title":"Organoid and Spheroid Tumor Models: Techniques and Applications","volume":"13","author":"Gunti","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118021_bib19","doi-asserted-by":"crossref","first-page":"25187","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2025.118021_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118021_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13205-021-02815-7","article-title":"Advances in development and application of human organoids","volume":"11","author":"Shankaran","year":"2021","journal-title":"3 Biotech"},{"issue":"4","key":"10.1016\/j.biopha.2025.118021_bib22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.stem.2019.08.002","article-title":"Complex Oscillatory Waves Emerging from Cortical Organoids Model Early Human Brain Network Development","volume":"25","author":"Trujillo","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.biopha.2025.118021_bib23","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/1568026033452096","article-title":"The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery","volume":"3","author":"Lin","year":"2003","journal-title":"Curr. Top. Med Chem."},{"issue":"18","key":"10.1016\/j.biopha.2025.118021_bib24","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1016\/j.cell.2021.08.005","article-title":"Organs-on-a-chip models for biological research","volume":"184","author":"Vunjak-Novakovic","year":"2021","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.biopha.2025.118021_bib25","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1039\/D0LC00424C","article-title":"Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety","volume":"20","author":"Chramiec","year":"2020","journal-title":"Lab Chip"},{"issue":"497","key":"10.1016\/j.biopha.2025.118021_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav1386","article-title":"Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics","volume":"11","author":"McAleer","year":"2019","journal-title":"Sci. Transl. Med"},{"issue":"7652","key":"10.1016\/j.biopha.2025.118021_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature22330","article-title":"Assembly of functionally integrated human forebrain spheroids","volume":"545","author":"Birey","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118021_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.593248","article-title":"Methadone Suppresses Neuronal Function and Maturation in Human Cortical Organoids","volume":"14","author":"Wu","year":"2020","journal-title":"Front Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118021_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005694","article-title":"PCSF: An R-package for network-based interpretation of high-throughput data","volume":"13","author":"Akhmedov","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.biopha.2025.118021_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinforma."},{"issue":"W1","key":"10.1016\/j.biopha.2025.118021_bib31","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118021_bib32","doi-asserted-by":"crossref","first-page":"22765","DOI":"10.1038\/s41598-021-01951-7","article-title":"A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates","volume":"11","author":"Strobel","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118021_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/bcp.12496","article-title":"Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations","volume":"79","author":"Teo","year":"2015","journal-title":"Br. J. Clin. Pharm."},{"issue":"3(3)","key":"10.1016\/j.biopha.2025.118021_bib34","first-page":"511","article-title":"Jr., Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.","volume":"108","author":"Rice","year":"2000","journal-title":"Environ. Health Perspect."},{"issue":"3","key":"10.1016\/j.biopha.2025.118021_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/004982500237668","article-title":"Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes","volume":"30","author":"Sahi","year":"2000","journal-title":"Xenobiotica"},{"issue":"8","key":"10.1016\/j.biopha.2025.118021_bib36","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/dmd.30.8.944","article-title":"Phenol sulfotransferase, ST1A3, as the main enzyme catalyzing sulfation of troglitazone in human liver","volume":"30","author":"Honma","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.biopha.2025.118021_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.slasd.2023.03.006","article-title":"In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models","volume":"28","author":"Lee","year":"2023","journal-title":"SLAS Discov."},{"issue":"2","key":"10.1016\/j.biopha.2025.118021_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: a decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7341","key":"10.1016\/j.biopha.2025.118021_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature09941","article-title":"Self-organizing optic-cup morphogenesis in three-dimensional culture","volume":"472","author":"Eiraku","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118021_bib40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neuroscience.2018.12.047","article-title":"Vincristine Impairs Microtubules and Causes Neurotoxicity in Cerebral Organoids","volume":"404","author":"Liu","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2025.118021_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.taap.2018.02.003","article-title":"Rotenone exerts developmental neurotoxicity in a human brain spheroid model","volume":"354","author":"Pamies","year":"2018","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.biopha.2025.118021_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111643","article-title":"Acrylamide exposure represses neuronal differentiation, induces cell apoptosis and promotes tau hyperphosphorylation in hESC-derived 3D cerebral organoids","volume":"144","author":"Bu","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118021_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-4547(19980515)52:4<435::AID-JNR7>3.0.CO;2-A","article-title":"Responses induced by tacrine in neuronal and non-neuronal cell lines","volume":"52","author":"De Ferrari","year":"1998","journal-title":"J. Neurosci. Res"},{"issue":"6","key":"10.1016\/j.biopha.2025.118021_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.205","article-title":"A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons","volume":"4","author":"Fujiki","year":"2013","journal-title":"Cell Death Dis."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118021_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0169-328X(98)00210-1","article-title":"Neuronal apoptosis induced by histone deacetylase inhibitors","volume":"61","author":"Salminen","year":"1998","journal-title":"Brain Res Mol. Brain Res"},{"issue":"3","key":"10.1016\/j.biopha.2025.118021_bib46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.taap.2010.08.007","article-title":"Multiple mechanisms underlying troglitazone-induced mitochondrial permeability transition","volume":"248","author":"Okuda","year":"2010","journal-title":"Toxicol. Appl. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118021_bib47","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12069","article-title":"The antidiabetic drug troglitazone protects against PrP (106\u2011126)\u2011induced neurotoxicity via the PPARgamma\u2011autophagy pathway in neuronal cells","volume":"23","author":"Moon","year":"2021","journal-title":"Mol. Med Rep."},{"issue":"5","key":"10.1016\/j.biopha.2025.118021_bib48","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/jnc.12264","article-title":"Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons","volume":"126","author":"Cho","year":"2013","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118021_bib49","first-page":"145","article-title":"Immune mechanisms of idiosyncratic drug-induced liver injury","volume":"3","author":"Mak","year":"2017","journal-title":"J. Clin. Transl. Res"},{"issue":"8","key":"10.1016\/j.biopha.2025.118021_bib50","doi-asserted-by":"crossref","first-page":"730","DOI":"10.21037\/atm-2020-ubih-05","article-title":"Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues","volume":"9","author":"Teschke","year":"2021","journal-title":"Ann. Transl. Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.118021_bib51","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","article-title":"DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans","volume":"21","author":"Chen","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.biopha.2025.118021_bib52","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s12035-017-0469-7","article-title":"Arsenic, Cadmium, and Lead Like Troglitazone Trigger PPARgamma-Dependent Poly (ADP-Ribose) Polymerase Expression and Subsequent Apoptosis in Rat Brain Astrocytes","volume":"55","author":"Kushwaha","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118021_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.514","article-title":"CDK5-induced p-PPARgamma(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes","volume":"5","author":"Rai","year":"2014","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.biopha.2025.118021_bib54","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1471-4159.1985.tb08793.x","article-title":"Blood-brain barrier transport of valproic acid","volume":"44","author":"Cornford","year":"1985","journal-title":"J. Neurochem."},{"issue":"22","key":"10.1016\/j.biopha.2025.118021_bib55","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0024-3205(96)00687-X","article-title":"Effect of valproate on the metabolism of the central nervous system","volume":"60","author":"Bolanos","year":"1997","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.biopha.2025.118021_bib56","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1872-034X.2007.00148.x","article-title":"Regulatory processes interacting to maintain hepatic blood flow constancy: Vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction","volume":"37","author":"Lautt","year":"2007","journal-title":"Hepatol. Res"},{"issue":"7","key":"10.1016\/j.biopha.2025.118021_bib57","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevFluids.6.070501","article-title":"Brain cerebrospinal fluid flow","volume":"6","author":"Kelley","year":"2021","journal-title":"Phys. Rev. Fluids"},{"issue":"5","key":"10.1016\/j.biopha.2025.118021_bib58","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0009-9236(95)90035-7","article-title":"Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans","volume":"57","author":"Dingemanse","year":"1995","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118021_bib59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/CIA.S3787","article-title":"Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease","volume":"4","author":"Truong","year":"2009","journal-title":"Clin. Inter. Aging"},{"issue":"2","key":"10.1016\/j.biopha.2025.118021_bib60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00003088-199937020-00001","article-title":"Clinical pharmacokinetics of troglitazone","volume":"37","author":"Loi","year":"1999","journal-title":"Clin. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118021_bib61","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.dmpk.2020.07.004","article-title":"Human plasma concentration-time profiles of troglitazone and troglitazone sulfate simulated by in vivo experiments with chimeric mice with humanized livers and semi-physiological pharmacokinetic modeling","volume":"35","author":"Ito","year":"2020","journal-title":"Drug Metab. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2025.118021_bib62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1081\/CLT-120019133","article-title":"Nefazodone poisoning: toxicokinetics and toxicodynamics using continuous data collection","volume":"41","author":"Isbister","year":"2003","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118021_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s002280050076","article-title":"Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation","volume":"50","author":"Barbhaiya","year":"1996","journal-title":"Eur. J. Clin. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.118021_bib64","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00044011-200323100-00005","article-title":"Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic Drugs","volume":"23","author":"Sommerville","year":"2003","journal-title":"Clin. Drug Invest."},{"issue":"12","key":"10.1016\/j.biopha.2025.118021_bib65","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2165\/00044011-200626120-00002","article-title":"Functional half-life is a meaningful descriptor of steady-state pharmacokinetics of an extended-release formulation of a rapidly cleared drug: as shown by once-daily divalproex-ER","volume":"26","author":"Dutta","year":"2006","journal-title":"Clin. Drug Invest."},{"issue":"1","key":"10.1016\/j.biopha.2025.118021_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Felbamate Study Group in Lennox-Gastaut, S., Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).","volume":"328","year":"1993","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2025.118021_bib67","series-title":"Felbamate","author":"Hanrahan","year":"2025"},{"issue":"6","key":"10.1016\/j.biopha.2025.118021_bib68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00003088-199528060-00003","article-title":"Clinical pharmacokinetics of tacrine","volume":"28","author":"Madden","year":"1995","journal-title":"Clin. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2025.118021_bib69","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.chemrestox.2c00360","article-title":"Mechanistic Study of Xanthotoxin-Mediated Inactivation of CYP1A2 and Related Drug-Drug Interaction with Tacrine","volume":"36","author":"Ran","year":"2023","journal-title":"Chem. Res Toxicol."},{"issue":"23","key":"10.1016\/j.biopha.2025.118021_bib70","doi-asserted-by":"crossref","first-page":"20321","DOI":"10.1021\/acsomega.2c02315","article-title":"Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using In Silico, In Vitro, and In Vivo Approaches","volume":"7","author":"Bhatt","year":"2022","journal-title":"ACS Omega"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:56:49Z","timestamp":1781823409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":70,"alternative-id":["S075333222500215X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118021","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-organ model assessment of neurotoxicity following exposure of liver spheroids to drugs","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118021"}}